Sun Pharma Announces Major Acquisition: Over Rs 3000 Crore Deal for US Oncology Firm
Sun Pharma, India's leading drugmaker, is set to acquire Checkpoint Therapeutics for over Rs 3000 crore, including the FDA-approved UNLOXCYT for advanced skin cancer. This move enh...